8:45am ET
Investing
Insiders Snap Up $54M in Biotech and Offshore Driller Stocks
In the past week or so, some public offerings prompted huge insider buying. However, these were not the only notable insider purchases recently.
Companies
/Healthcare
PepGen Inc
$3.02
▼ $0.13 (−4.13%) today
Markets closed · 3:58am ET
Today · % change
Fundamentals
Market Cap
$217.9M
EPS (TTM)
$-1.00
52-Week Range
$1 – $8
Street Target
$10.19
About PepGen
PepGen Inc. is a pioneering biotechnology firm based in Boston, Massachusetts, dedicated to advancing the treatment of severe neuromuscular and neurologic diseases. With a focus on oligonucleotide therapeutics, its flagship product, PGN-EDO51, is currently undergoing Phase I clinical trials aimed at combating Duchenne muscular dystrophy. Additionally, PepGen is exploring treatments for myotonic dystrophy type 1 and other forms of muscular dystrophy, demonstrating its commitment to addressing unmet medical needs in the neuromuscular field since its inception in 2018.
PEPG Coverage
11:20am ET
Investing
Insider Buying: Taking a Controlling Stake in a Struggling Retailer?
A beneficial owner stepped up and took a controlling stake in a struggling retailer, while public offerings of stock prompted insider buying at some biotech companies.